Minimal clinically important difference for acupuncture for patients with chronic spontaneous urticaria: secondary analysis from a multicentre randomised controlled trial in China.


Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
29 Oct 2024
Historique:
medline: 31 10 2024
pubmed: 31 10 2024
entrez: 30 10 2024
Statut: epublish

Résumé

To evaluate the minimal clinically important difference (MCID) value for acupuncture treatment in chronic spontaneous urticaria (CSU), providing guidance for its application in CSU management. Secondary analysis of data from a multicentre randomised controlled trial. Three tertiary hospitals across three cities in China. 103 CSU patients (78.7% female) with an average age of 39.97 years. Participants received acupuncture treatment for 4 weeks in the original study. MCID and minimal detectable change (MDC) for the Urticaria Activity Score over 7 days (UAS7) in acupuncture treatment of CSU. Convergent validity assessed by intraclass correlation coefficient (ICC). Responsiveness evaluated through Spearman correlation between UAS7 improvements and anchor tools (physician's and patient's assessments). MDC calculated using SE of measurement of changes in UAS7 scores. MCID estimated using distribution-based and anchor-based methods. The ICC for UAS7 was 0.86. Improvements in UAS7 scores were significantly correlated with patient (r=0.44, p<0.01) and physician (r=0.85, p<0.01) assessments of CSU activity shifts. The MDC for UAS7 was 5.08. The MCID for acupuncture treatment in CSU was 8.3. This study provides the first MCID value for acupuncture treatment in CSU. These findings contribute to the understanding of acupuncture's effects in treating CSU and may inform future research and clinical practice in the management of this condition. ChiCTR1900022994.

Identifiants

pubmed: 39477260
pii: bmjopen-2024-085041
doi: 10.1136/bmjopen-2024-085041
doi:

Types de publication

Journal Article Multicenter Study Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Pagination

e085041

Informations de copyright

© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Auteurs

Xianjun Xiao (X)

School of Health Preservation and Rehabilitation, Chengdu University of Traditional Chinese Medicine, Chengdu, China.

Wei Cao (W)

Disease Prevention Center, Chengdu First People's Hospital, Chengdu, China.

Zihao Zou (Z)

College of Acupuncture and Tuina, Chengdu University of Traditional Chinese Medicine, Chengdu, China.

Sijue Chen (S)

College of Acupuncture and Tuina, Chengdu University of Traditional Chinese Medicine, Chengdu, China.

Qian Yang (Q)

College of Acupuncture and Tuina, Chengdu University of Traditional Chinese Medicine, Chengdu, China.

Di Qin (D)

College of Acupuncture and Tuina, Chengdu University of Traditional Chinese Medicine, Chengdu, China.

Peiwen Xue (P)

School of Health Preservation and Rehabilitation, Chengdu University of Traditional Chinese Medicine, Chengdu, China.

Lu Wang (L)

Department of Acupuncture and Rehabilitation, Hospital of Chengdu Universily of TCM, Chengdu, China.

Menghan Xi (M)

College of Acupuncture and Tuina, Chengdu University of Traditional Chinese Medicine, Chengdu, China.

Ying Li (Y)

College of Acupuncture and Tuina, Chengdu University of Traditional Chinese Medicine, Chengdu, China.

Haiyan Qin (H)

Department of Acupuncture and Moxibustion, Shenzhen University First Affiliated Hospital, Shenzhen, Guangdong, China.

Yunzhou Shi (Y)

College of Acupuncture and Tuina, Chengdu University of Traditional Chinese Medicine, Chengdu, China shiyunzhou@cdutcm.edu.cn.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH